JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB180902

Anti-FLI1 antibody - C-terminal

Be the first to review this product! 리뷰 제출

|

(5 제품이 사용된 논문 )

Rabbit Polyclonal FLI1 antibody. C-terminal. Suitable for WB, ICC/IF and reacts with Human samples. Cited in 5 publications. Immunogen corresponding to Synthetic Peptide within Human FLI1.
2 이미지
Immunocytochemistry/ Immunofluorescence - Anti-FLI1 antibody - C-terminal (AB180902)
  • ICC/IF

Supplier Data

Immunocytochemistry/ Immunofluorescence - Anti-FLI1 antibody - C-terminal (AB180902)

Immunofluorescent analysis of HeLa cells labeling FLI1 with ab180902 at 5 μg/ml.

Western blot - Anti-FLI1 antibody - C-terminal (AB180902)
  • WB

Supplier Data

Western blot - Anti-FLI1 antibody - C-terminal (AB180902)

Lane 1:

Western blot - Anti-FLI1 antibody - C-terminal (ab180902) at 0.5 µg/mL

Lane 2:

Western blot - Anti-FLI1 antibody - C-terminal (ab180902) at 1 µg/mL

All lanes:

Jurkat cell lysate at 15 µg

Predicted band size: 51 kDa

Observed band size: 52 kDa

false

주요 정보

Host species

Rabbit

Clonality

Polyclonal

Isotype

IgG

Carrier free

No

Reacts with

Human

Applications

ICC/IF, WB

applications

Immunogen

Synthetic Peptide within Human FLI1. The exact immunogen used to generate this antibody is proprietary information.

Q01543

Specificity

At least four isoforms of FLI1 are known to exist; this antibody will detect all four.

Reactivity 정보

{ "title": "Reactivity Data", "filters": { "stats": ["", "Species", "Dilution Info", "Notes"], "tabs": { "all-applications": {"fullname" : "All Applications", "shortname": "All Applications"}, "WB" : {"fullname" : "Western blot", "shortname":"WB"}, "ICCIF" : {"fullname" : "Immunocytochemistry/ Immunofluorescence", "shortname":"ICC/IF"} }, "product-promise": { "all": "all", "testedAndGuaranteed": "tested", "guaranteed": "expected", "predicted": "predicted", "notRecommended": "not-recommended" } }, "values": { "Human": { "WB-species-checked": "testedAndGuaranteed", "WB-species-dilution-info": "0.5-1 µg/mL", "WB-species-notes": "<p></p>", "ICCIF-species-checked": "testedAndGuaranteed", "ICCIF-species-dilution-info": "5 µg/mL", "ICCIF-species-notes": "<p></p>" } } }

특성 및 보관 정보

제형
Liquid
Purification 테크닉
Affinity purification Immunogen
보관 버퍼
pH: 7.2 Preservative: 0.02% Sodium azide Constituents: PBS
배송 시 보관 조건
Blue Ice
적절한 단기 보관 기간
1-2 weeks
적절한 단기 보관 조건
+4°C
적절한 장기 보관 조건
-20°C
분주 정보
Upon delivery aliquot
보관 정보
Avoid freeze / thaw cycle

추가 정보

This supplementary information is collated from multiple sources and compiled automatically.

The FLI1 protein also known as Friend leukemia virus integration 1 acts as a transcription factor. It consists of 452 amino acids resulting in a molecular mass of about 50 kDa. FLI1 is part of the ETS (E26 transformation-specific) family of transcription factors and it binds to specific DNA sequences to regulate the expression of various genes. It expresses in hematopoietic cells endothelial cells and several tissues during development. High expression levels in certain tissues suggest a significant role in diverse cellular functions.
Biological function summary

The FLI1 protein influences cell proliferation differentiation and apoptosis. It also plays a role in the regulation of genes involved in the immune response. FLI1 forms complexes with other proteins to exert its function therefore impacting gene expression in cellular contexts. Its participation in these processes indicates its regulatory impact on normal cellular development and function.

Pathways

FLI1 interacts with signaling networks that govern the hematopoietic lineage and endothelial cell function. It participates in the MAPK/ERK pathway influencing cell cycle and growth signaling. Through these pathways FLI1 has functional interactions with proteins such as GATA1 and RUNX1 establishing its importance in vascular development and hematopoiesis.

FLI1 has significant associations with Ewing sarcoma and certain leukemias. In Ewing sarcoma chromosomal translocations involve FLI1 leading to oncogenic fusion proteins that drive tumorigenesis. It also interacts with partners like EWSR1 in this context. Moreover abnormal levels of FLI1 relate to blood disorders due to its role in hematopoietic regulation. Understanding these interactions and associations aids in developing therapeutic strategies targeting these illnesses.

제품 프로토콜

For this product, it's our understanding that no specific protocols are required. You can visit:

타겟 정보

Sequence-specific transcriptional activator (PubMed : 24100448, PubMed : 26316623, PubMed : 28255014). Recognizes the DNA sequence 5'-C[CA]GGAAGT-3'.
See full target information FLI1

대체 명칭 보기

Friend leukemia integration 1 transcription factor, Proto-oncogene Fli-1, Transcription factor ERGB, FLI1

제품이 사용된 논문 (5)

Recent publications for all applications. Explore the 전체 목록and refine your search

Haematologica 110:2792-2798 PubMed40468949

2025

Characterization of a novel mutation in a family with thrombocytopenia and other congenital malformations.

Applications

Unspecified application

Species

Unspecified reactive species

Daniele Ammeti,Serena Barozzi,Alessandro Pecci,Melania Eva Zanchetta,Edward Cesnik,Alessandra Ferlini,Mariabeatrice Sanchini,Laura Verga,Valeria Bozzi,Fabio Corsolini,Michela Faleschini,Anna Savoia,Stefania Bigoni

Advanced science (Weinheim, Baden-Wurttemberg, Germany) 8:e2004846 PubMed34060252

2021

SPOP and OTUD7A Control EWS-FLI1 Protein Stability to Govern Ewing Sarcoma Growth.

Applications

Unspecified application

Species

Unspecified reactive species

Siyuan Su,Jianfeng Chen,Yao Jiang,Ying Wang,Tamara Vital,Jiaming Zhang,Christian Laggner,Kong T Nguyen,Zhichuan Zhu,Alex W Prevatte,Natalie K Barker,Laura E Herring,Ian J Davis,Pengda Liu

Oncology letters 15:2795-2800 PubMed29435006

2018

PRL-3 promotes breast cancer progression by downregulating p14-mediated p53 expression.

Applications

Unspecified application

Species

Unspecified reactive species

Hua Xie,Hao Wang

Annals of the rheumatic diseases 76:924-934 PubMed28062404

2017

Endothelial-to-mesenchymal transition contributes to endothelial dysfunction and dermal fibrosis in systemic sclerosis.

Applications

Unspecified application

Species

Unspecified reactive species

Mirko Manetti,Eloisa Romano,Irene Rosa,Serena Guiducci,Silvia Bellando-Randone,Amato De Paulis,Lidia Ibba-Manneschi,Marco Matucci-Cerinic

Annals of the rheumatic diseases 75:1541-9 PubMed26359450

2015

Decreased expression of neuropilin-1 as a novel key factor contributing to peripheral microvasculopathy and defective angiogenesis in systemic sclerosis.

Applications

Unspecified application

Species

Unspecified reactive species

Eloisa Romano,Inês Chora,Mirko Manetti,Celestina Mazzotta,Irene Rosa,Silvia Bellando-Randone,Jelena Blagojevic,Raquel Soares,Jerôme Avouac,Yannick Allanore,Lidia Ibba-Manneschi,Marco Matucci-Cerinic,Serena Guiducci
제품이 사용된 논문 모두 보기

Product promise

저희는 고품질 시약으로 고객님의 연구를 서포트하고자 최선을 다하고 있으며, 모든 단계에서 함께 하겠습니다. 만약 제품이 기대한 성능을 보이지 않을 경우에도 Product Promise로 보호받으실 수 있습니다.
자세한 내용은 이용 약관을 확인해 주세요.

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com